| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/03/2011 | CN101035763B Process for producing heteroaromatic carboxylic acids |
| 08/02/2011 | US7989661 Human ADAM-10 inhibitors |
| 08/02/2011 | US7989660 Bactericide against gramnegative bacteria; respiaratory system disorders |
| 08/02/2011 | US7989634 Melanocortin receptor agonists |
| 08/02/2011 | US7989633 4-Chromenonyl-1,4-dihydropyridines and their use |
| 08/02/2011 | US7989498 Inhibitors of IMPDH enzyme |
| 08/02/2011 | US7989478 Cinnamoyl compound and use of the same |
| 08/02/2011 | US7989477 Monocyclic heterocycles as kinase inhibitors |
| 08/02/2011 | US7989476 Electron-transporting materials and processes for making the same |
| 08/02/2011 | US7989457 Used to treat diabetic and other glucagon related metabolic disorders such as obesity, hyperglycemia, atherosclerosis, ischemic heart disease, stroke, neuropathy, and wound healing; (R,S)-Methanesulfonic acid 2-(3-methyl-4'-trifluoromethyl-biphenyl-4-yl)-propyl ester |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 07/28/2011 | WO2011090122A1 Method for producing 2-amino-4-(trifluoromethyl)pyridine |
| 07/28/2011 | WO2011089576A2 NOVEL COMPOSITIONS FOR REDUCING Aß 42 PRODUCTION AND THEIR USE IN TREATING ALZHEIMER'S DISEASE (AD) |
| 07/28/2011 | WO2011088561A1 Anti-viral compounds and compositions |
| 07/28/2011 | WO2011088549A1 Derivatives of pyridoxine for inhibiting hiv integrase |
| 07/28/2011 | US20110184184 METHOD FOR SEPARATING AND PURIFYING alpha- UNSATURATED AMINE COMPOUND |
| 07/28/2011 | US20110184032 Novel Phenylamino Isonicotinamide Compounds |
| 07/28/2011 | US20110184030 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate |
| 07/28/2011 | US20110184029 Pyridone derivatives as non-nucleoside reverse transcriptase inhibitors |
| 07/28/2011 | US20110184028 Derivatives of pyridoxine for inhibiting hiv integrase |
| 07/28/2011 | US20110184020 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions |
| 07/28/2011 | US20110183998 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 07/28/2011 | US20110183981 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/28/2011 | US20110183980 O-benzyl nicotinamide analogs as mglur5 positive allosteric modulators |
| 07/28/2011 | US20110183957 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 07/28/2011 | US20110183940 Chemical compounds |
| 07/28/2011 | US20110182833 Carboxamide Derivatives Having Cooling Properties |
| 07/28/2011 | CA2786666A1 Novel compositions for reducing abeta 42 production and their use in treating alzheimer's disease (ad) |
| 07/27/2011 | EP2346828A1 Piperazine derivatives used as cav2.2 calcium channel modulators |
| 07/27/2011 | EP2346827A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors |
| 07/27/2011 | EP2346826A2 Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine |
| 07/27/2011 | EP2346825A2 Modulators of p2x3 receptor activity |
| 07/27/2011 | EP2346821A1 Sphingosine-1-phosphate receptor antagonists |
| 07/27/2011 | EP2346819A1 Naphthylacetic acids |
| 07/27/2011 | EP2061762B1 Pyrazine compounds, their use and methods of preparation |
| 07/27/2011 | EP1848695B1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 07/27/2011 | EP1689713B1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease |
| 07/27/2011 | EP1638964B1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/27/2011 | EP1443928B1 Treatment of neurodegenerative diseases and cancer of the brain |
| 07/27/2011 | CN1930139B Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 07/27/2011 | CN102137846A N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275)polymorph b |
| 07/27/2011 | CN102137845A Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines |
| 07/27/2011 | CN102137841A Ortho-substituted haloalkylsulfonanilide derivative and herbicide |
| 07/27/2011 | CN102134241A Synthesis method of xanthinol nicotinate |
| 07/27/2011 | CN102134232A Isotopically substituted pantoprazole |
| 07/27/2011 | CN102134218A 6-aryl amino pyridone sulfamide and 6-aryl amino pymetrozine sulfamide methyl ethyl ketone (MEK) inihibitor |
| 07/27/2011 | CN102134175A Preparation method of benzyl fluorine organic compound |
| 07/27/2011 | CN102133523A Method for re-activating inactivated catalyst through catalytic chlorination of pyridine nitrile |
| 07/27/2011 | CN101774967B Method for preparing 2, 6-dichloro-5-fluorine nicotinoyl ethyl acetate |
| 07/27/2011 | CN101703501B Propargyl imine compounds and use thereof in preparation of MAO inhibitor |
| 07/27/2011 | CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use |
| 07/27/2011 | CN101538241B 4-(4-pyridyl) phenylformic acid complex material and preparation method and application thereof |
| 07/27/2011 | CN101302190B Method for preparing 2,3-dichloropyridine |
| 07/27/2011 | CN101239311B Method for converting cyanopyridine compounds into niacinamide compounds, its catalyst and the catalyst preparation |
| 07/27/2011 | CN101094835B Novel dicarboxamide derivatives |
| 07/27/2011 | CN101080390B Process for the preparation of a 2-ethylaminopyridine derivative |
| 07/26/2011 | US7985863 Iminopyridine derivatives and uses thereof |
| 07/26/2011 | US7985862 Iminopyridine derivatives and use thereof |
| 07/26/2011 | US7985830 Method for making nitrogen aromatic oligomers and polymers |
| 07/26/2011 | CA2469625C Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 07/26/2011 | CA2445344C Heterocyclic compound derivatives and medicines |
| 07/21/2011 | WO2011086935A1 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same |
| 07/21/2011 | WO2011086931A1 Three-dimensional structure and manufacturing method for same |
| 07/21/2011 | WO2011086531A2 New anti-malarial agents |
| 07/21/2011 | WO2011085964A1 Electrolyte formulations |
| 07/21/2011 | WO2011061330A3 Use of physiological cooling active ingredients, and agents containing such active ingredients |
| 07/21/2011 | WO2010126607A3 Synthesis of tetracyclines and intermediates thereto |
| 07/21/2011 | US20110178396 Nicotinamide Derivatives |
| 07/21/2011 | US20110178305 Process for the preparation of 3,4-epoxy-2-amino-1-substituted butane derivatives and intermediate compounds thereof |
| 07/21/2011 | US20110178302 Nucleophilic fluorination of aromatic compounds |
| 07/21/2011 | US20110178137 Diaryl urea for treating heart failure |
| 07/21/2011 | US20110178136 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/21/2011 | US20110178120 Hiv integrase inhibitors from pyridoxine |
| 07/21/2011 | US20110178104 Anti-Heparin Compounds |
| 07/21/2011 | US20110178102 Sir2 regulation |
| 07/21/2011 | US20110178089 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 07/21/2011 | US20110178087 Compositions and Their Use as Anti-Tumor Agents |
| 07/21/2011 | US20110178055 Dual nk1/nk3 receptor antagonists |
| 07/21/2011 | US20110178042 Hydroxamic Acid Derivatives Useful as Antibacterial Agents |
| 07/21/2011 | CA2787121A1 New anti-malarial agents |
| 07/20/2011 | EP2345640A1 Adamantyl- acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/20/2011 | EP2344486A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 07/20/2011 | EP2344449A1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use |
| 07/20/2011 | EP2344160A1 Tryptophan hydroxylase inhibitors and methods of their use |
| 07/20/2011 | EP1817282B1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 07/20/2011 | EP1753839B1 Polymer light-emitting material and organic light emitting element |
| 07/20/2011 | EP1697312B1 Hydroxamic acid esters and pharmaceutical use thereof |
| 07/20/2011 | EP1481966B1 Novel arylamidine derivative or salt thereof |
| 07/20/2011 | CN102131782A Pyridine derivatives as VEGF-2 receptor and protein tyrosine kinase inhibitors |
| 07/20/2011 | CN102131781A 1-(4-ureidobenzoyl)piperazine derivatives |
| 07/20/2011 | CN102131760A Metal complex and manufacturing method therefor |
| 07/20/2011 | CN102127056A Tubulin inhibitors |
| 07/20/2011 | CN102127030A 4-(substituted-1,3-dialkynyl)-4-(trifluoromethyl)benzo-1,4-dihydroxazole-2-one compounds and preparation method and applications thereof |
| 07/20/2011 | CN102127013A 2-hydroxyl-1-naphthalene-3-pyridinecarbonylhydrazone and preparation method and applications thereof |
| 07/20/2011 | CN102127012A Pyridone compound |
| 07/20/2011 | CN102127011A Method and equipment for synthesizing polychloropyridine and derivatives thereof by chlorination catalyzed by active carbon |
| 07/20/2011 | CN102127010A Preparation method of greenish yellow light-emitting material using pyridine as donor unit |
| 07/20/2011 | CN102127009A Substituted pyridine ionic liquid and application thereof |
| 07/20/2011 | CN102127008A Method for recycling pyridine from chemical production wastewater |
| 07/20/2011 | CN102127003A Intermediate compound of anti-flu medicine Tamiflu and synthesis method and applications thereof |